Showing 1 - 8 results of 8 for search 'Michele Graciotti', query time: 0.04s Refine Results
  1. 1
    Correction: A cancer vaccine with dendritic cells differentiated with GM-CSF and IFNα and pulsed with a squaric acid treated cell lysate improves T cell priming and tumor growth control in a mouse model

    Correction: A cancer vaccine with dendritic cells differentiated with GM-CSF and IFNα and pulsed with a squaric acid treated cell lysate improves T cell priming and tumor growth co... by Ananda Mookerjee, Michele Graciotti, Lana E. Kandalaft

    Published 2019-01-01
    Get full text
    Article
  2. 2
    A cancer vaccine with dendritic cells differentiated with GM-CSF and IFNα and pulsed with a squaric acid treated cell lysate improves T cell priming and tumor growth control in a mouse model

    A cancer vaccine with dendritic cells differentiated with GM-CSF and IFNα and pulsed with a squaric acid treated cell lysate improves T cell priming and tumor growth control in a m... by Ananda Mookerjee, Michele Graciotti, Lana E. Kandalaft

    Published 2018-05-01
    Get full text
    Article
  3. 3
    IL-15 and a Two-Step Maturation Process Improve Bone Marrow-Derived Dendritic Cell Cancer Vaccine

    IL-15 and a Two-Step Maturation Process Improve Bone Marrow-Derived Dendritic Cell Cancer Vaccine by Ananda Mookerjee, Michele Graciotti, Lana E. Kandalaft

    Published 2019-01-01
    Get full text
    Article
  4. 4
    The era of bioengineering: how will this affect the next generation of cancer immunotherapy?

    The era of bioengineering: how will this affect the next generation of cancer immunotherapy? by Michele Graciotti, Cristiana Berti, Harm-Anton Klok, Lana Kandalaft

    Published 2017-06-01
    Get full text
    Article
  5. 5
    Does the Immunocompetent Status of Cancer Patients Have an Impact on Therapeutic DC Vaccination Strategies?

    Does the Immunocompetent Status of Cancer Patients Have an Impact on Therapeutic DC Vaccination Strategies? by Silvia Martin Lluesma, Michele Graciotti, Cheryl Lai-Lai Chiang, Lana E. Kandalaft

    Published 2018-11-01
    Get full text
    Article
  6. 6
    Predicting combinations of immunomodulators to enhance dendritic cell-based vaccination based on a hybrid experimental and computational platform

    Predicting combinations of immunomodulators to enhance dendritic cell-based vaccination based on a hybrid experimental and computational platform by Rita Ahmed, Isaac Crespo, Sandra Tuyaerts, Amel Bekkar, Michele Graciotti, Ioannis Xenarios, Lana E. Kandalaft

    Published 2020-01-01
    Get full text
    Article
  7. 7
    Deciphering the Mechanisms of Improved Immunogenicity of Hypochlorous Acid-Treated Antigens in Anti-Cancer Dendritic Cell-Based Vaccines

    Deciphering the Mechanisms of Improved Immunogenicity of Hypochlorous Acid-Treated Antigens in Anti-Cancer Dendritic Cell-Based Vaccines by Michele Graciotti, Fabio Marino, HuiSong Pak, Petra Baumgaertner, Anne-Christine Thierry, Johanna Chiffelle, Marta A. S. Perez, Vincent Zoete, Alexandre Harari, Michal Bassani-Sternberg, Lana E. Kandalaft

    Published 2020-06-01
    Get full text
    Article
  8. 8
    Cancer vaccines based on whole-tumor lysate or neoepitopes with validated HLA binding outperform those with predicted HLA-binding affinity

    Cancer vaccines based on whole-tumor lysate or neoepitopes with validated HLA binding outperform those with predicted HLA-binding affinity by Hajer Fritah, Michele Graciotti, Cheryl Lai-Lai Chiang, Anne-Laure Huguenin- Bergenat, Rémy Petremand, Ritaparna Ahmed, Philippe Guillaume, Julien Schmidt, Brian J. Stevenson, David Gfeller, Alexandre Harari, Lana E. Kandalaft

    Published 2023-04-01
    Get full text
    Article

Search Tools: